The decision is another win for the Biden administration in a bitter legal fight with several drugmakers over the constitutionality of the price talks. Read this story
The decision is another win for the Biden administration in a bitter legal fight with several drugmakers over the constitutionality of the price talks. Read this story
More from CNBC | Business Biotechnology Biotech and Pharmaceuticals Pharmaceuticals Health care industry Bristol-Myers Squibb Co Social issues Joe Biden Johnson & Johnson Government and politics business news cnbc Articles US: News Companies Business News Health & Science source:tagname:CNBC US Source